Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Casi Pharmaceuticals Inc (CASI)  
$1.63 0.00 (0.00%) as of 4:30 Mon 3/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,940,000
Market Cap: 202.02(M)
Last Volume: 38,851 Avg Vol: 19,828
52 Week Range: $1.63 - $1.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 371,517
Total Buy Value $0 $0 $0 $1,315,104
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 11
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 159
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-02-22 4 B $0.01 $6,801 I/I 680,113 2,856,868 1.5     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-02-22 4 B $0.01 $10,088 D/D 1,008,764 4,237,391 2.37     -
   Wong Cynthia COO   •       –      –    2016-01-19 4 B $0.72 $12,111 D/D 16,800 17,785 2.74     -
   Ren Ken Keyong CEO and Director   •       •      –    2016-01-19 4 B $0.71 $10,894 D/D 15,000 15,000 2.81     -
   Ren Ken CEO and Director   •       •      –    2016-01-19 4 B $0.71 $10,894 D/D 15,000 15,000 2.81     -
   Shong Hugo 10% Owner   –       –       •   2016-01-14 3 IO $0.00 $0 D/D 0 4,744,910     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2014-09-17 3 IO $0.00 $0 I/I 0 2,176,755     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2014-09-17 3 IO $0.00 $0 D/D 0 3,228,627     -
   Huang James Director   –       •      –    2013-04-04 3 IO $0.00 $0 I/I 0 416,666     -
   Zhou Quan 10% Owner   –       –       •   2013-03-07 4 B $2.40 $165,499 I/I 68,958 360,947 1.5     -
   Zhou Quan 10% Owner   –       –       •   2013-03-07 4 B $2.40 $2,334,499 D/D 972,708 5,091,438 2.45     -
   Mak Tak W. Director   –       •      –    2012-05-01 4 B $0.00 $0 D/D 352,857 365,376 2.31     -
   Wong Cynthia COO, General Counsel and Secy   •       –      –    2012-05-01 4 B $0.00 $0 I/I 74,982 74,982 1.91     -
   He Wei-Wu Director   –       •      –    2012-05-01 4 B $0.00 $0 I/I 441,072 441,072 2.02     -
   Zhou Quan 10% Owner   –       –       •   2012-04-30 3 IO $0.00 $0 I/I 0 291,989     -
   Zhou Quan 10% Owner   –       –       •   2012-04-30 3 IO $0.00 $0 D/D 0 4,118,730     -
   Mak Tak W. Director   –       •      –    2012-02-02 3 IO $0.00 $0 D/D 0 12,519     -
   He Wei-Wu Director   –       •      –    2012-02-02 3 IO $0.00 $0 D/D 0 24,698     -
   Bush Dwight L Director   –       •      –    2011-06-17 4 GD $0.00 $0 D/D 2,871 7,592     -
   Wong Cynthia VP,General Counsel,& Secretary   •       –      –    2008-09-17 4 B $0.40 $1,000 D/D 2,500 10,833 2.66     -
   Burns James S President and CEO   •       •      –    2008-09-16 4 B $0.29 $13,137 D/D 45,300 185,300 2.81     -
   Burns James S President and CEO   •       •      –    2008-07-10 4 B $0.53 $5,300 D/D 10,000 140,000 2.81     -
   Brooks Donald S Director   –       •      –    2008-06-05 4 A $0.00 $0 D/D 39,063 95,102     -
   Randall Mark C M Director   –       •      –    2008-06-05 4 A $0.00 $0 D/D 39,063 95,102     -
   Tarnow Michael M Director   –       •      –    2008-06-05 4 A $0.00 $0 D/D 39,063 115,549     -

  159 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed